Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Other Working Capital Changes: 2019-2025

Historic Other Working Capital Changes for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to $2.3 million.

  • Biodesix's Other Working Capital Changes rose 564.39% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 1705.22%. This contributed to the annual value of -$716,000 for FY2024, which is 20.88% up from last year.
  • Per Biodesix's latest filing, its Other Working Capital Changes stood at $2.3 million for Q3 2025, which was up 2,364.08% from -$103,000 recorded in Q2 2025.
  • Biodesix's 5-year Other Working Capital Changes high stood at $2.3 million for Q3 2025, and its period low was -$1.7 million during Q2 2024.
  • For the 3-year period, Biodesix's Other Working Capital Changes averaged around $35,727, with its median value being -$103,000 (2025).
  • In the last 5 years, Biodesix's Other Working Capital Changes plummeted by 186.59% in 2021 and then surged by 564.39% in 2025.
  • Biodesix's Other Working Capital Changes (Quarterly) stood at $1.2 million in 2021, then crashed by 44.68% to $655,000 in 2022, then surged by 36.34% to $893,000 in 2023, then tumbled by 93.06% to $62,000 in 2024, then soared by 564.39% to $2.3 million in 2025.
  • Its Other Working Capital Changes stands at $2.3 million for Q3 2025, versus -$103,000 for Q2 2025 and -$215,000 for Q1 2025.